Abstract

Background: Spinal hemangioblastoma (HB) is a highly vascularized tumor commonly presenting in the lower thoracic and lumbar segments. It typically causes spinal compression, extensive bleeding, and/or syringomyelia.

Case Description: A 32-year-old female presented with persistent headaches with a cervical MRI showing an intradural and extradural mass extending from the obex to C2. Following surgical tumor resection, the patient’s symptoms resolved.

Conclusion: Resection of spinal HB requires direct removal of the tumor mass as the accompanying cystic components typically spontaneously regress.

Keywords: Cervical hemangioblastoma, Fenestration, Hemangioblastoma surgery, Intra and extradural, Syringomyelia

INTRODUCTION

Spinal hemangioblastomas (HBs) are slow-growing and highly vascularized tumors, accounting for 2–15% of primary spinal cord malignancies. They can arise as an isolated lesion or as multiple tumors spread throughout the central nervous system in association with syringomyelia, intramedullary hemorrhages, or Von Hippel-Lindau (VHL) syndrome (in 20–30% of the cases).[ 2 , 4 ] Clinically, they contribute to varying degrees of myelopathy that correlate with the location of the tumor mass and accompanying abnormalities. Here, we describe a 32-year-old female with a cervical, intra- and extra-medullary HB extending from the obex to C2 resulting in headaches and numbness in the upper extremities.

CASE PRESENTATION

A 32-year-old female presented with occipital headaches and sudden onset of numbness in the upper extremities with gait instability without focal neurological deficits (Mc Cormick grade II). The cervical MRI with gadolinium showed an oval mass in the intradural space at the obex extending to the superior margin of C2 markedly enhancing following the administration of contrast and associated with syringomyelia extending from the obex to C6 [ Figure 1 ].

Figure 1:

(a) Sagittal and (b) coronal T1-weighted image demonstrating the posterolateral hyperintense lesion infiltrating the spinal cord located between obex and the posterior arch of C2 (red arrow) with associated syringomyelia extending from the tumor to C6 (white arrow).

Surgery

The patient underwent suboccipital craniectomy and total C1 laminectomy for complete removal of the intra and extramedullary mass under continuous spinal cord monitoring. Intraoperatively, the lesion was red and elastic in consistency, richly vascularized, and extended to the central canal of the spinal cord [ Figure 2 ].

Figure 2:

(a and b) Intraoperative images showing the subdural, intra/extra-axial lesion localization, which was completely removed after spinal cord exposure, following a complete C1 laminectomy and suboccipital craniotomy.

Postoperative course

Postoperatively, the gait was slightly impaired, while the headaches subsided, but the hypoesthesia in the upper extremities remained unchanged. The postoperative MRI demonstrated total tumor removal with a reduction of the syrinx. The patient was discharged 7 days later without focal deficits (Mc Cormick Grade I). At 6 months of follow-up, the patient had no residual complaints or deficits. Further, the MRI confirmed no tumor recurrence and a significant reduction of the accompanying syringomyelia [ Figure 3 ].

Figure 3:

Follow-up MRI showing gross total removal of the HBL and reduction of the syrinx.

Pathology

The pathological examination confirmed the diagnosis of a capillary HBL. It showed groups of large polygonal, lipid-laden stromal cells, interspersed with thin-walled, and closely packed blood-filled channels or vessels. Immunohistochemical staining revealed the presence of stromal cells positive for inhibin A and NSE while immunonegative for CD10 and EMA [ Figure 4 ].

Figure 4:

(a) (× 40) and (b) (× 100) pathological examination with hematoxylin and eosin staining revealed large, stromal cells rich in lipids, and intertwined with thin-walled capillaries. C Immunohistochemical staining with inhibin A showing marked positivity of the neoplastic cells.

DISCUSSION

Sporadic spinal HBs usually present as a single lesion,[ 7 ] mostly occupying the cervical area, followed by the thoracic and lumbosacral segment, with a relative incidence of 50.4%, 36.4%, and 13.4%, respectively.[ 7 , 10 ] Most of the reported spinal HBs are intramedullary[ 6 , 10 ] and located in the dorsal area of the spinal cord [ Table 1 ],[ 5 , 7 , 9 ] specifically in the posterior region of the denticulate ligament. MRI remains the gold standard, with T1-weighted imaging showing homogeneous, hyperintense signal, and T2-weighted imaging (T2WI) reflecting the highly vascularized nature that commonly characterizes these lesions. Additional information obtained with T2WI includes the demarcation of myelocoele in adjacent segments and the presence and extension of associated syringomyelia. Regardless of the location of the tumor in relation to the dura mater, these lesions almost always exhibit a marked enhancement after gadolinium administration.[ 2 ]

Table 1:

Summary of the cited cases.

Management options

The most effective and definitive treatment for spinal HB are represented by microsurgical resection, which should only be considered if neurological deficits are present. In VHL patients with multiple small lesions, gamma-knife radiosurgery has shown promising results although further evidence is foreseen to recommend this treatment.[ 3 , 7 ] Other factors that need to be acknowledged when considering preoperative embolization are the location of the tumor, its gross vascular anatomy, and the embolization material.[ 3 , 8 ]

Prognosis

Gross-total resection (i.e., minimally invasive cytoreductive surgery under neurophysiological monitoring) can be achieved in over 90% of the cases and can result in full functional recovery in 96% of cases.[ 3 , 5 , 10 ] In general, symptoms tend to spontaneously regress within 1–2 weeks after surgical tumor resection, whereas improvement of associated conditions such as cord enlargement, cyst, or syrinx requires between 3 and 6 months.[ 10 ] The use of radiosurgery or presurgical embolization remains highly controversial, as they provide no clear therapeutic benefit but can result in hemorrhage, medullary infarction, and radionecrosis.[ 1 , 3 , 10 ]

Recurrence of HB

Moreover, recurrence is frequently seen after partial resections[ 10 ] accounting for 6.25–7.7% of the cases.[ 10 ] Survival rates for sporadic HBs at 10 years are >90% and causes of death are mostly associated with other factors, that is, other cancerous manifestations of VHL.[ 5 ]

CONCLUSION

Spinal cervical HBs are rare malignancies and are best managed with gross total resection without the need for complete syrinx excision.

Declaration of patient consent

Patient’s consent not required as patient’s identity is not disclosed or compromised.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

References

1. Ampie L, Choy W, Khanna R, Smith ZA, Dahdaleh NS, Parsa AT. Role of preoperative embolization for intradural spinal hemangioblastomas. J Clin Neurosci. 2016. 24: 83-7

2. Barrey C, Kalamarides M, Polivka M, George B. Cervical dumbbell intra-extradural hemangioblastoma: Total removal through the lateral approach: Technical case report. Neurosurgery. 2005. 56: E625

3. Chang H, Li J, Wang P, Lu X, Li B. Microsurgical treatment of cervical spinal hemangioblastoma. Neurochirurgie. 2020. 66: 56-60

4. Colamaria A, Sacco M, Iodice S, D’Oria Parbonetti G, Carbone F. Intradural extramedullary cavernous hemangioma of the cervicothoracic junction: A case report and review of the literature. Surg Neurol Int. 2022. 13: 53

5. D’Oria S, Giraldi D, Fanelli V, D’Angelo V.editors. Sporadic hemangioblastoma of cauda equina: A case-report and brief literature review. Neurocirugía. 2022. p.

6. Gluf WM, Dailey AT. Hemorrhagic intramedullary hemangioblastoma of the cervical spinal cord presenting with acute-onset quadriparesis: Case report and review of the literature. J Spinal Cord Med. 2014. 37: 791-4

7. Kim JH, Joo SM, Cho YE, Ha SW, Suh SH. Percutaneous onyx embolization of recurrent cervical nerve root hemangioblastoma: A case report and review of the literature. Clin Neuroradiol. 2021. 31: 1209-13

8. Li D, Choe S, Borys E, Serrone JC, Germanwala AV. Primary intradural extramedullary sporadic spinal hemangioblastomas: Case report and systematic review. World Neurosurg. 2021. 152: 84-94

9. Sun Hİ, Özduman K, Usseli Mİ, Özgen S, Pamir MN. Sporadic spinal hemangioblastomas can be effectively treated by microsurgery alone. World Neurosurg. 2014. 82: 836-47

10. Takai K, Taniguchi M, Takahashi H, Usui M, Saito N. Comparative analysis of spinal hemangioblastomas in sporadic disease and Von Hippel-Lindau syndrome. Neurol Med Chir (Tokyo). 2010. 50: 560-7